Results 81 to 90 of about 10,799 (115)

Histidine-improved cancer immunosurveillance. [PDF]

Oncoimmunology
Fidelle M, Reich E, Zitvogel L, Kroemer G.   +3 more
europepmc   +1 more source

Prognostic value of [¹⁸F]FDG PET/CT and PERCIST criteria in patients with HER2-low metastatic breast cancer treated with trastuzumab deruxtecan. [PDF]

Eur J Nucl Med Mol Imaging
Frega J, Somme L, Martin T, Petit T, Salvadori J, Bund C, Somme F.   +6 more
europepmc   +1 more source

Sensorineural hearing loss after pediatric cranial radiotherapy: a multicenter analysis of dosimetric and clinical risk factors. [PDF]

Support Care Cancer
Gehin W, Ollivier L, Jouglar E, Dossun C, Jolnerovski M, Bernier-Chastagner V.   +5 more
europepmc   +1 more source

Beyond Mankind, Self-Illusion and Medical Expertise of Artificial Intelligence in the Era of COVID-19. [PDF]

Open Forum Infect Dis
Claessens A, Claessens YE, Lambert A, Gehin W.   +3 more
europepmc   +1 more source

Patients with Cancer and Immune Checkpoint Inhibitor-Induced Rheumatic irAEs Treated by DMARDs: The RHUMICI Single-Centre Retrospective Cohort. [PDF]

Cancers (Basel)
Massy E, Seiller J, Piperno M, Bonnelye E, Maillet D, Dalle S, Fontaine-Delaruelle C, Souquet PJ, Péron J, Confavreux CB.   +9 more
europepmc   +1 more source

Characteristics, treatment and survival of older patients with metastatic triple negative breast cancer from the ESME mBC real-world national cohort: a comparison with younger women. [PDF]

Breast
Mairé M, Bouteiller F, Chakiba C, Jacot W, Geiss R, Ung M, Goncalves A, Frenel JS, Bailleux C, Perrin C, Massard V, Mailliez A, Jouannaud C, Cherifi F, Petit T, Terret C, Viansone A, Bosquet L, Galvin A.   +18 more
europepmc   +1 more source

Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort. [PDF]

Breast
Alexandre M, Teruel E, Dalenc F, de la Motte Rouge T, Brain E, Massard V, Arnedos M, Mailliez A, Ferrero JM, Bachelot T, Desmoulins I, Mouret-Reynier MA, Levy C, Gonçalves A, Berghian A, Petit T, Frenel JS, Martin AL, Grinda T, Jacot W.   +19 more
europepmc   +1 more source

Baseline value and longitudinal kinetics of circulating nucleosomes during neo-adjuvant chemotherapy in newly diagnosed ovarian cancer: Results from a GINECO/GINEGEPS study of the randomized phase II CHIVA trial. [PDF]

Transl Oncol
Corbaux P, Colomban O, Lescuyer G, Ray-Coquard I, De Rauglaudre G, Joly F, Abdeddaim C, Combe P, Blonz C, Bataillon G, Meunier J, Alexandre J, Berton D, Kaminsky MC, Bello Roufai D, Leary A, Venat L, Dohollou N, Louvet C, Lebreton C, Abadie-Lacourtoisie S, Lotz JP, Favier L, Fabbro M, Bonichon-Lamichhane N, Kurtz JE, Follana P, Pujade-Lauraine E, Payen L, You B.   +29 more
europepmc   +1 more source

AI-Driven Patient Screening for Clinical Trials in Pancreatic Cancer: The PANCR-AI Pilot Retrospective Comparative Study. [PDF]

JMIR Cancer
Claessens A, Simon A, Manchart A, Desmonts L, Leguay C, Faivre JC, Cambier S, Salleron J, Lambert A.   +8 more
europepmc   +1 more source

Comparative analysis of artificial intelligence-based contouring of cardiac substructures on computed tomography scans for radiation therapy. [PDF]

Phys Imaging Radiat Oncol
Moignier A, Perennec T, Prangères E, Bernard B, Botticella A, Chen X, Finnegan R, Huger S, Karlhede A, Lacornerie T, Löfman F, Palisson J, Robert C, Sambourg K, Söderberg J, Stoica R, Delpon G, Martin-Mervoyer E, Thillays F, Vaugier L.   +19 more
europepmc   +1 more source